Usage image of Ybrain's home-use electronic medicine for depression, 'Mindsteem'

Usage image of Ybrain's home-use electronic medicine for depression, 'Mindsteem'

View original image

[Asia Economy Reporter Chunhee Lee] Mental health electronic medicine platform company Ybrain announced on the 4th that the first non-reimbursed prescription of the prescription depression electronic medicine 'Mindsteem' has been made.


According to Ybrain, on the 1st, the first in-hospital treatment using a non-reimbursed prescription of Mindsteem for depression treatment was conducted at Seoul The Naeun Mental Health Clinic in Songpa-gu, Seoul. This prescription was made for a woman in her 30s who visited due to depressive symptoms while preparing for pregnancy, considering the patient's concerns about drug treatment, and thus prescribed the electronic medicine Mindsteem.


The company expects that with this prescription, following last year's marketing authorization by the Ministry of Food and Drug Safety, last month's selection as a new medical technology exemption by the Ministry of Health and Welfare, and the non-reimbursed notification, the non-reimbursed prescription of Mindsteem will be fully activated.


Jongbin Bae, director of Seoul The Naeun Mental Health Clinic, said, “The first female patient treated with Mindsteem expressed that her anxiety decreased and was satisfied with the treatment as she received it comfortably without any significant adverse reactions,” adding, “Unlike drugs, it is safe from side effects, helping women of childbearing age with depression to receive more active treatment either in-hospital or at home.”



Kiwon Lee, CEO of Ybrain, also said, “Since Mindsteem was notified as non-reimbursed last month, inquiries about its introduction from psychiatric clinics have increased,” and added, “For patients who have experienced side effects from existing antidepressant treatments or those who had difficulty being treated with antidepressants alone, Mindsteem will present a new paradigm for non-drug depression treatment.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing